To ensure Exablate Prime met the needs of working neurosurgeons, it was tested first in Rambam Hospital in Haifa, Israel where suggestions for improvement were implemented. It was then tested in the US by Oregon Health and Science University.
"We were proud to lead the validation pilot study for Prime and be a design partner with Insightec," said Dr. Lior Lev Tov, senior neurosurgeon at Rambam Hospital. We truly appreciate the great improvements it brings to the treatment."
Exablate Prime is available for sale in the US and Europe. For more information about Exablate Prime or to schedule a demonstration, please contact marketing@insightec.com
About Insightec
Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson's disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo.
Back to HCB News
